Leung HY - Search Results

1

Serum keratinocyte growth factor measurement in patients with prostate cancer.

Mehta PB, Robson CN, Neal DE, Leung HY. Mehta PB, et al. Among authors: leung hy. J Urol. 2000 Dec;164(6):2151-5. J Urol. 2000. PMID: 11061946

2

Peptide growth factors in the prostate as mediators of stromal epithelial interaction.

Byrne RL, Leung H, Neal DE. Byrne RL, et al. Br J Urol. 1996 May;77(5):627-33. doi: 10.1046/j.1464-410x.1996.09721.x. Br J Urol. 1996. PMID: 8689101 Review.

3

Fibroblast growth factor receptor-2 mutation analysis in human prostate cancer.

Mehta P, Robson CN, Neal DE, Leung HY. Mehta P, et al. Among authors: leung hy. BJU Int. 2000 Oct;86(6):681-5. doi: 10.1046/j.1464-410x.2000.00893.x. BJU Int. 2000. PMID: 11069376

4

Androgen receptor signalling in the prostate.

Gnanapragasam VJ, Robson CN, Leung HY, Neal DE. Gnanapragasam VJ, et al. Among authors: leung hy. BJU Int. 2000 Dec;86(9):1001-13. doi: 10.1046/j.1464-410x.2000.00943.x. BJU Int. 2000. PMID: 11119093 Review. No abstract available.

5

Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.

West AF, O'Donnell M, Charlton RG, Neal DE, Leung HY. West AF, et al. Among authors: leung hy. Br J Cancer. 2001 Aug 17;85(4):576-83. doi: 10.1054/bjoc.2001.1971. Br J Cancer. 2001. PMID: 11506499 Free PMC article.

6

Keratinocyte growth factor activates p38 MAPK to induce stress fibre formation in human prostate DU145 cells.

Mehta PB, Robson CN, Neal DE, Leung HY. Mehta PB, et al. Among authors: leung hy. Oncogene. 2001 Aug 30;20(38):5359-65. doi: 10.1038/sj.onc.1204688. Oncogene. 2001. PMID: 11536048

7

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.

Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN. Gnanapragasam VJ, et al. Among authors: leung hy. Br J Cancer. 2001 Dec 14;85(12):1928-36. doi: 10.1054/bjoc.2001.2179. Br J Cancer. 2001. PMID: 11747336 Free PMC article.

8

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.

Drake MJ, Robson W, Mehta P, Schofield I, Neal DE, Leung HY. Drake MJ, et al. Among authors: leung hy. Br J Cancer. 2003 Mar 24;88(6):822-7. doi: 10.1038/sj.bjc.6600817. Br J Cancer. 2003. PMID: 12644816 Free PMC article. Clinical Trial.

9

FGF8 isoform b expression in human prostate cancer.

Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY. Gnanapragasam VJ, et al. Among authors: leung hy. Br J Cancer. 2003 May 6;88(9):1432-8. doi: 10.1038/sj.bjc.6600875. Br J Cancer. 2003. PMID: 12778074 Free PMC article.

10

Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate.

Halkidou K, Cook S, Leung HY, Neal DE, Robson CN. Halkidou K, et al. Among authors: leung hy. Eur Urol. 2004 Mar;45(3):382-9; author reply 389. doi: 10.1016/j.eururo.2003.10.005. Eur Urol. 2004. PMID: 15036687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters